The study shows that more high-income countries used compulsory licensing to gain access to medicines. These countries thus obtained cheaper medicines through forced licenses. Compulsory licenses allow the production or import of generic versions of medicines without the consent of the patent holder. The study highlights the growing trend of their use in developed economies. This approach helps reduce healthcare costs. Several such countries have already applied this mechanism in practice. The findings of the study point to a wider use of compulsory licenses in recent years.